Suppressive effects of F-1322 on the antigen-induced late asthmatic response and pulmonary eosinophilia in guinea pigs

European Journal of Pharmacology

Volumn 430, Issue 1, 2001, Pages 123-133

  Mochizuki, Akinori ^a   Tamura, Norihiko ^a   Yatabe, Yoriko ^a   Onodera, Sadayoshi ^a   Hiruma, Toru ^a   Inaba, Niro ^a   Kusunoki, Jun ^a   Tomioka, Hisao ^b  

^a FUJIREBIO INC   (Japan)

^b TOHO UNIVERSITY SCHOOL OF MEDICINE   (Japan)

Author keywords

(Guinea pig); Anti asthmatic agent; Asthma; Asthmatic response; Eosinophil migration; F 1322; Late

Indexed keywords

ACTIN; ANTIHISTAMINIC AGENT; ARACHIDONATE 5 LIPOXYGENASE; ASCARIS ANTIGEN; EOTAXIN; F 1322; INTERLEUKIN 5; N [2 [4 (BENZHYDRYLOXY)PIPERIDINO]ETHYL] 3 HYDROXY 5 (3 PYRIDYLMETHOXY) 2 NAPHTHAMIDE; THROMBOXANE SYNTHASE; THROMBOXANE SYNTHASE INHIBITOR; UNCLASSIFIED DRUG;

AIRWAY; ALLERGIC ASTHMA; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CELL MIGRATION; CHEMOTAXIS; CONCENTRATION RESPONSE; CONTROLLED STUDY; DOSE RESPONSE; DRUG EFFECT; EOSINOPHIL; GUINEA PIG; HISTOPATHOLOGY; LOEFFLER PNEUMONIA; LUNG LAVAGE; LYMPHOCYTOPENIA; MALE; NONHUMAN; POLYMERIZATION; PRIORITY JOURNAL;

AIRWAY RESISTANCE; ALLERGENS; ANIMALS; ANTI-ASTHMATIC AGENTS; ANTIGENS, HELMINTH; ASTHMA; BRONCHOALVEOLAR LAVAGE FLUID; CELL MOVEMENT; CELLS, CULTURED; CHEMOKINES, CC; CHEMOTAXIS; DISEASE MODELS, ANIMAL; EOSINOPHILIA; EOSINOPHILS; GUINEA PIGS; INTERLEUKIN-5; LUNG DISEASES; NAPHTHALENES; TIME FACTORS;

EID: 0035955388     PISSN: 00142999     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0014-2999(01)01364-4     Document Type: Article

References (43)

1. Effect of a novel anti-inflammatory compound, YM976, on antigen-induced eosinophil infiltration into the lungs in rats, mice, and ferrets
2. Effect of YM158, a dual lipid mediator antagonist, on immediate and late asthmatic responses, and on airway hyper-responsiveness in guinea pigs
3. Effect of YM264 on the airway hyperresponsiveness and the late asthmatic response in a guinea pig model of asthma
4. Eosinophilic inflammation in asthma
5. Eosinophils in asthma
6. Allergen-induced increase in bronchial responsiveness to histamine: Relationship to the late asthmatic response and change in airway caliber
7. In vitro pharmacology of the novel phosphodiesterase type 4 inhibitor, CP-80633
8. Cooperation between interleukin-5 and the chemokine eotaxin to induce eosinophil accumulation in vivo
9. Bronchoalveolar eosinophilia during allergen-induced late asthmatic reactions
10. Effects of a selective PDE4 inhibitor, D-22888, on human airways and eosinophils in vitro and late phase allergic pulmonary eosinophilia in guinea pigs
11. Comparative contractile responses to sulfidopeptide leukotrienes in normal and asthmatic human subjects
12. Pharmacology of the eosinophil
13. Asthma therapy modulates priming-associated blood eosinophil responsiveness in allergic asthmatics
14. Late-phase asthmatic responses and airway inflammation
15. Symposium on allergic lung disease: II. The late asthmatic responses
16. Chemotactic peptide modulation of actin assembly and locomotion in neutrophils
17. Montelukast, a leukotriene receptor antagonist, inhibits the late airway response to antigen, airway eosinophilia, and IL-5-expressing cells in Brown Norway rats
18. Bronchoalveolar lavage and histologic characterization of late asthmatic response in guinea pigs
19. Effects of CS-518, a thromboxane synthase inhibitor, on eosinophil function
20. Effects of a thromboxane synthase inhibitor (CS-518) on the eosinophil-dependent late asthmatic response and airway hyperresponsiveness in guinea pigs
21. Thromboxane A2 production in allergen-induced immediate and late asthmatic responses. Its possible role in inducing the late response
22. Contribution of upper airways to antigen-induced late airway obstructive responses in guinea pigs
23. Inhibition of antigen-induced eosinophilia and late phase airway hyperresponsiveness by an IL-5 antisense oligonucleotide in mouse models of asthma
24. Effects of an interleukin-5 blocking monoclonal antibody on eosinophils, airway hyper-responsiveness, and the late asthmatic response
25. Pharmacological profiles of F-1322, a novel anti-asthmatic agent: (1) Mechanisms of action
26. Pharmacological modulation of immediate and late airway response and leukocyte infiltration in the guinea pig
27. Inhibitory effect of F-1322 on allergic eosinophil infiltration in airways
28. Effects of intracellular cyclic AMP modulators on human eosinophil survival, degranulation and CD11b expression
29. Relationship between interleukin-5 and eotaxin in regulating blood and tissue eosinophilia in mice
30. Blockade of eosinophil migration by 5-lipoxygenase and cyclooxygenase inhibition in explanted guinea pig trachealis
31. Late asthmatic responses
32. A noninvasive technique for measurement of changes in specific airway resistance
33. Production of eosinophil-rich guinea pig peritoneal exudates
34. Pharmacology and biochemistry of the leukotrienes
35. Late asthmatic responses induced by ragweed pollen allergen
36. Combined antagonism of leukotrienes and histamine produces predominant inhibition of allergen-induced early and late phase airway obstruction in asthmatics
37. Relationships among allergen-induced early and late phase airway obstructions, bronchial hyperreactivity, and inflammation in conscious, unrestrained guinea pigs
38. New concepts: The basophil
39. Eosinophil accumulation and activation in antigen-induced late asthmatic response in guinea pigs
40. Regulation of homocytotropic antibody formation in the rat: I. Feed-back regulation by passively administered antibody
41. The inhibitory effect of TMK688, a novel anti-allergic drug having both 5-lipoxygenase inhibitory activity and anti-histamine activity, against bronchoconstriction, leukotriene production and inflammatory cell infiltration in sensitized guinea pigs
42. Bronchoalveolar lavage fluid mediator levels 5 minutes after allergen challenge in atopic subjects with asthma: Relationship to the development of late asthmatic responses
43. Effect of suplatast tosilate (IPD-1151T) on a mouse model of asthma: Inhibition of eosinophilic inflammation and bronchial hyperresponsiveness